Amenorrhea screening: Difference between revisions

Jump to navigation Jump to search
Eiman (talk | contribs)
No edit summary
Eiman (talk | contribs)
No edit summary
Line 2: Line 2:
{{Amenorrhea}}
{{Amenorrhea}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}{{EG}}
==Overview==
==Overview==



Revision as of 16:58, 26 September 2017

Amenorrhea Microchapters

Home

Patient Information

Primary amenorrhea
Secondary amenorrhea

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amenorrhea from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amenorrhea screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amenorrhea screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amenorrhea screening

CDC on Amenorrhea screening

Amenorrhea screening in the news

Blogs on Amenorrhea screening

Directions to Hospitals Treating Amenorrhea

Risk calculators and risk factors for Amenorrhea screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Overview

According to the US Preventive Services Task Force (USPSTF), there is insufficient evidence to recommend routine screening for amenorrhea.

Screening

References

Template:WH Template:WS